Abstract:Objectives: This study aimed to systematically investigate whether plaque autofluorescence properties assessed with intravascular fluorescence lifetime imaging (FLIm) can provide qualitative and quantitative information about intimal composition and improve the characterization of atherosclerosis lesions. Background: Despite advances in cardiovascular diagnostics, the analytic tools and imaging technologies currently available have limited capabilities for evaluating in situ biochemical changes associated with luminal surface features. Earlier studies of small number of samples have shown differences among the autofluorescence lifetime signature of well-defined lesions, but a systematic pixel-level evaluation of fluorescence signatures associated with various histological features is lacking and needed to better understand the origins of fluorescence contrast. Methods: Human coronary artery segments (n = 32) were analyzed with a bimodal catheter system combining multispectral FLIm with intravascular ultrasonography compatible with in vivo coronary imaging. Various histological components present along the luminal surface (200-μm depth) were systematically tabulated (12 sectors) from each serial histological section (n = 204). Morphological information provided by ultrasonography allowed for the accurate registration of imaging data with histology data. The relationships between histological findings and FLIm parameters obtained from 3 spectral channels at each measurement location (n = 33,980) were characterized. Results: Our findings indicate that fluorescence lifetime from different spectral bands can be used to quantitatively predict the superficial presence of macrophage foam cells (mFCs) (area under the receiver-operator characteristic curve: 0.94) and extracellular lipid content in advanced lesions (lifetime increase in 540-nm band), detect superficial calcium (lifetime decrease in 450-nm band area under the receiver-operator characteristic curve: 0.90), and possibly detect lesions consistent with active plaque formation such as pathological intimal thickening and healed thrombus regions (lifetime increase in 390-nm band). Conclusions: Our findings indicate that autofluorescence lifetime provides valuable information for characterizing atherosclerotic lesions in coronary arteries. Specifically, FLIm can be used to identify key phenomena linked with plaque progression (e.g., peroxidized-lipid-rich mFC accumulation and recent plaque formation).

Label Free Assessment of Key Biological Autofluorophores: Material Characteristics and Opportunities for Clinical Applications

Optical Tissue Diagnostics Based on Label-free, Functional Biomarkers

Two-photon Excited Fluorescence of Intrinsic Fluorophores Enables Label-Free Assessment of Adipose Tissue Function

Tissue Imaging and Quantification Relying on Endogenous Contrast

Autofluorescence of blood and its application in biomedical and clinical research

Mapping Metabolic Changes by Noninvasive, Multiparametric, High-Resolution Imaging Using Endogenous Contrast.

Towards label‐free non‐invasive autofluorescence multispectral imaging for melanoma diagnosis

Fluorescence intensity and lifetime imaging of lipofuscin-like autofluorescence for label-free predicting clinical drug response in cancer

Luminescent Nanomaterials for Biological Labelling

Reduced background autofluorescence for cell imaging using nanodiamonds and lanthanide chelates

Label-Free Visualization and Quantification of Biochemical Markers of Atherosclerotic Plaque Progression Using Intravascular Fluorescence Lifetime

Emerging Fluorescent Nanoparticles for Non-Invasive Bioimaging

Persistent Luminescence Nanosensors: A Generalized Optode-based Platform for Autofluorescence-free Sensing in Biological Systems

Robust Organic Nanoparticles for Noninvasive Long-Term Fluorescence Imaging

Development of Low-Cost Instrumentation for Single Point Autofluorescence Lifetime Measurements

Novel post-acquisition image processing to attenuate red blood cell autofluorescence for quantitative image analysis

Assessing the sensitivity of commercially available fluorophores to the intracellular environment.

Long‐Term Intracellular Tracking of Label‐Free Nanoparticles in Live Cells and Tissues with Confocal Microscopy

Label-Free Metabolic Imaging In Vivo by Two-Photon Fluorescence Lifetime Endomicroscopy

Activatable small molecular luminescence probes for autofluorescence-free bioimaging

Autofluorescence lifetime flow cytometry with time-correlated single photon counting